瘤化疗后的细胞毒性治疗后的急性髓性白血病:一个病例报告
Masahiro Manabe1, Yoko Tani2, Naoyuki Inano3
1Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka 545-0053, Japan.
Medicine international
|January 29, 2024
概括
本案例研究突出了一个罕见的急性髓性白血病细胞毒性治疗后 (AML-pCT) 发生在胸腺瘤治疗后的罕见案例. 对这种潜在的晚期并发症的认识对于接受乳头瘤化疗的患者至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 胸腺瘤是胸腺腺的罕见瘤.
- 化疗是晚期胸腺瘤的常见治疗方式.
- 二次性恶性瘤,如髓状瘤,可以在细胞毒性治疗后出现.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.3K
